Publications du GEMO

2019

French recommendations for osteoporosis prevention and treatment in patients with prostate cancer treated by androgen deprivation

Briot K, Paccou J, Beuzeboc P, Bonneterre J, Bouvard B, Confavreux CB, Cormier C, Cortet B, Hannoun-Lévi JM, Hennequin C, Javier RM, Lespessailles E, Mayeur D, Mongiat Artus P, Vieillard MH, Debiais F

Journal: Joint Bone Spine
Volume: 86, Issue 1
Année: Janvier 2019
Pages: 21-28

https://doi.org/10.1016/j.jbspin.2018.09.017

2018

TMPRSS2:ERG gene fusion expression regulates bone markers and enhances the osteoblastic phenotype of prostate cancer bone metastases

Delliaux C, Tian TV, Bouchet M, Fradet A, Vanpouille N, Florens A, Deplus R, Villers A, Leroy X, Clézardin P, De Launoit Y, Bonnelye E, Duterque-Coquillaud M

Journal: Cancer Letters
Volume: 438
Année: Décembre 2018
Pages: 32-43

https://doi.org/10.1016/j.canlet.2018.08.027

Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion

Body JJ, von Moos R, Niepel D, Tombal B

Journal: BMC Urology
Volume: 18, Issue 1
Année: Septembre 2018
Pages: 81

https://doi.org/10.1186/s12894-018-0393-9

Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapy

Chalopin A, Tellez-Gabriel M, Brown HK, Vallette F, Heymann MF, Gouin F, Heymann D

Journal: Journal of Bone Oncology
Volume: 12
Année: Septembre 2018
Pages: 83-90

https://doi.org/10.1016/j.jbo.2018.07.002

Paradoxical side effects of bisphosphonates on the skeleton: What do we know and what can we do?

Vargas-Franco JW, Castaneda B, Rédiní F, Gómez DF, Heymann D, Lézot F

Journal: Journal of Cellular Physiology
Volume: 233, Issue 8
Année: Août 2018
Pages: 5696-5715

https://doi.org/10.1002/jcp.26465

Bidirectional regulation of bone formation by exogenous and osteosarcoma-derived Sema3A

de Ridder D, Marino S, Bishop RT, Renema N, Chenu C, Heymann D, Idris AI

Journal: Scientific Reports
Volume: 8, Issue 1
Année: Mai 2018
Pages: 6877

https://doi.org/10.1038/s41598-018-25290-2

Biology of Bone Sarcomas and New Therapeutic Developments

Brown HK, Schiavone K, Gouin F, Heymann MF, Heymann D

Journal: Calcified Tissue International
Volume: 102, Issue 4
Année: Avril 2018
Pages: 174-195

https://link.springer.com/article/10.1007%2Fs00223-017-0372-2

Total Hip Arthroplasty for Periacetabular Metastatic Disease. An Original Technique of Reconstruction According to the Harrington Classification

Wegrzyn J, Malatray M, Al-Qahtani T, Pibarot V, Confavreux C, Freyer G

Journal: The Journal of Arthroplasty
Volume: 33, Issue 8
Année: Mars 2018
Pages: 2546-2555

https://doi.org/10.1016/j.arth.2018.02.096

Decision Making for the Surgical Treatment of Vertebral Metastases Among Patients with Short Predicted Survival

Bouras T, Zairi F, Arikat A, Vieillard MH, Allaoui M, Assaker R

Journal: World Neurosurgery
Volume: 111
Année: Mars 2018
Pages: 573-580

https://doi.org/10.1016/j.wneu.2017.12.107

Bone, muscle, and metabolic parameters predict survival in patients with synchronous bone metastases from lung cancers

Chambard L, Girard N, Ollier E, Rousseau JC, Duboeuf F, Carlier MC, Brevet M, Szulc P, Pialat JB, Wegrzyn J, Clezardin P, Confavreux CB

Journal: Bone
Volume: 108
Année: Mars 2018
Pages: 202-209

https://doi.org/10.1016/j.bone.2018.01.004